Matthew Harris
Founder at CLARITY PHARMACEUTICALS LTD
Net worth: 34 M $ as of 2024-04-29
Profile
Matthew Harris is the founder and the Technology Director at Clarity Pharmaceuticals Ltd., a company founded in 2010.
He was previously the Chief Executive Officer at Gateway Capital Ltd.
and a Non-Executive Director at Genera Biosystems Ltd.
from 2007 to 2008.
Dr. Harris holds a doctorate degree from the Australian National University and an MBA from the Australian Graduate School of Management.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-04-07 | 18,788,460 ( 6.93% ) | 34 M $ | 2024-04-29 |
Matthew Harris active positions
| Companies | Position | Start |
|---|---|---|
| CLARITY PHARMACEUTICALS LTD | Founder | 2009-12-31 |
Former positions of Matthew Harris
| Companies | Position | End |
|---|---|---|
| GENERA BIOSYSTEMS LIMITED | Director/Board Member | 2008-12-11 |
Gateway Capital Ltd.
 Gateway Capital Ltd. Financial ConglomeratesFinance Gateway Capital Ltd. is an investment firm. | President | - |
Training of Matthew Harris
| Australian Graduate School of Management | Masters Business Admin |
| Australian National University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| CLARITY PHARMACEUTICALS LTD | Health Technology |
| Private companies | 2 |
|---|---|
Gateway Capital Ltd.
Gateway Capital Ltd. Financial ConglomeratesFinance Gateway Capital Ltd. is an investment firm. | Finance |
Genera Biosystems Ltd.
 Genera Biosystems Ltd. Medical SpecialtiesHealth Technology Genera Biosystems Ltd. is a molecular diagnostics company, which engages in the development and commercialization of molecular diagnostic tests. Its products include PapType and RTIplex. The company was founded by Karl Poetter on November 6, 2001 and is headquartered in Scoresby, Australia. | Health Technology |
- Stock Market
- Insiders
- Matthew Harris